abstract |
FIELD: pharmacology. n SUBSTANCE: invention relates to indoline-2-one derivatives, the formula A, which are protein kinase inhibitors for the treatment of hyperproliferative diseases such as lung cancer, colorectal cancer, liver cancer and acute myelomonocytic leukemia. n EFFECT: increased efficiency of treatment. n 15 cl, 3 dwg, 6 tbl, 1 ex |